Govind leads Imperial Innovations' Venture Support Unit, dedicated to entrepreneurship at Imperial. The Venture Support Unit is responsible for all aspects of the development of new spin-outs from Imperial, working with both staff and students, in addition to managing the incubator and part of the spin-out portfolio. During his time at Innovations has led the formation of over 40 companies and is on the board of a number of these companies. In the last few years he has led the sale of several Imperial spinouts to companies including Google, Evonik and Oxford University Press. Prior to Innovations, Govind was the European Director of Technology for a US semiconductor equipment company (Novellus Systems) where he led a team based around Europe responsible for the introduction of new technology. In his early career Govind was a scientist at the Cavendish labs in Cambridge University and in Japan. Govind has a BSc in Chemical Physics from University of Sussex, PhD in Semiconductor Physics from University of Warwick and an MBA from Imperial College business school.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.